Inventor · disambiguated record
Catherine Anne Sabatos-Peyton
Also filed as: SABATOS-PEYTON CATHERINE A · SABATOS-PEYTON CATHERINE ANNE
14 granted patents·14 pending applications·321 citations·filing 2014–2024
94Inventor score
Files withNOVARTIS AG23DRANOFF GLENN2BRIGHAM & WOMENS HOSPITAL1BRIGHAM & WOMENS HOSPITAL INC1CREMASCO VIVIANA1
Top patents by PatentIndex Score
28 records- 0199US9683048B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2015·Granted Jun 20, 2017·115 cites·144 claims
- 0298US10981990B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2020·Granted Apr 20, 2021·11 cites·30 claims
- 0398US10711060B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·29 cites·5 claims
- 0498US9815898B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 14, 2017·35 cites·30 claims
- 0598US9605070B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 28, 2017·67 cites·85 claims
- 0696US10752687B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2017·Granted Aug 25, 2020·6 cites·90 claims
- 0796US9908936B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Mar 6, 2018·23 cites·30 claims
- 0895US11155620B2Method of detecting TIM-3 using antibody molecules to TIM-3NOVARTIS AG·Filed 2019·Granted Oct 26, 2021·6 cites·20 claims
- 0994US11827704B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2020·Granted Nov 28, 2023·2 cites·43 claims
- 1093US10472419B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 12, 2019·12 cites·57 claims
- 1193US9884913B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Feb 6, 2018·12 cites·30 claims
- 1290US2025066479A1Antibody molecules to pd-1 and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1382US2025213684A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2024·Application pending·0 cites
- 1478US2022185883A1Method of detecting tim-3 using antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1575US9962440B2Methods related to TIM 3, a TH1-specific cell surface molecule, for activating antigen presenting cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted May 8, 2018·1 cites·17 claims
- 1675US9346876B2TIM-3 ligands and methods of modulating immune responsesBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 24, 2016·2 cites·7 claims
- 1773US12252535B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2020·Granted Mar 18, 2025·0 cites·10 claims
- 1870US2022133889A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1968US2023039109A1Antibody molecules to cd73 and uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2067US2023013364A1Combination therapies comprising antibody molecules to pd-1NOVARTIS AG·Filed 2021·Application pending·0 cites
- 2156US2018207273A1Combination therapies comprising antibody molecules to tim-3DRANOFF GLENN·Filed 2016·Application pending·0 cites
- 2253US2015259420A1Antibody molecules to lag-3 and uses thereofNOVARTIS AG·Filed 2015·Application pending·0 cites
- 2347US2018222982A1Combination therapies comprising antibody molecules to pd-1DRANOFF GLENN·Filed 2016·Application pending·0 cites
- 2445US2020223924A1Dosage regimens for anti-tim-3 antibodies and uses thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2545US2020172628A1Antibody molecules to cd73 and uses thereofCREMASCO VIVIANA·Filed 2018·Application pending·0 cites
- 2644US2021214459A1Antibody molecules to cd73 and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2742US2020277378A1Combination therapiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2840US2018340025A1Combination therapies comprising antibody molecules to lag-3NOVARTIS AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →